Inhaled iloprost improves right ventricular load-independent contractility in pulmonary hypertension

Inhaled iloprost improves right ventricular load-independent contractility in pulmonary hypertension

Background: The adaptation of the right ventricular contractility to its afterload (RV–PA coupling), best measured by the ratio of end-systolic elastance (Ees) and arterial elastance (Ea), is a key determinant for prognosis and symptomatology in pulmonary hypertension...
Μακροπρόθεσμη αποτελεσματικότητα και ασφάλεια του sotatercept για τη θεραπεία της πνευμονικής αρτηριακής υπέρτασης (ΠΑΥ)

Μακροπρόθεσμη αποτελεσματικότητα και ασφάλεια του sotatercept για τη θεραπεία της πνευμονικής αρτηριακής υπέρτασης (ΠΑΥ)

PULSAR open-label extension: Long-term efficacy and safety of sotatercept for the treatment of pulmonary arterial hypertension (PAH) Pulmonary arterial hypertension (PAH) is a progressive disease driven by pulmonary vascular remodeling. Sotatercept acts as a...

Pulmonary Hypertension and Pregnancy

Pulmonary hypertension (PH) is a rare, life-threatening disease that affects the pulmonary arteries, the lungs, and the heart. Patients who suffer from the disease have narrow and obstructed pulmonary arteries — the vessels responsible for transporting blood from the...
Translate »

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!